学术放射肿瘤学队伍中的疾病部位专业化:性别差异的证据
该研究通过2020年1月公开的学术放射肿瘤科(ARO)科室网站收集1337名教职人员的性别与诊治疾病部位,分析性别与疾病部位专业化的关系。结果显示女性占30.5%,乳腺、妇科和儿科女性比例最高(均>40%,P<.001),泌尿生殖、胸部和头颈女性比例最低(均<25%,P<.001)。女性治疗乳腺和妇科肿瘤的可能性是男性的两倍,男性治疗泌尿生殖肿瘤的可能性是女性的三倍,但男女平均治疗部位数无差异(2.63 vs 2.53;P=.29)。
要点
- 女性占学术放射肿瘤学教职人员的30.5%(408/1337)。
- 乳腺、妇科、儿科中女性比例均>40%(P<.001),泌尿生殖、胸部、头颈均<25%(P<.001)。
- 女性治疗乳腺和妇科肿瘤的风险比分别为2.01和2.06,男性治疗泌尿生殖肿瘤的风险比为0.40。
核心结论
- 在学术放射肿瘤学中观察到疾病部位专业化的性别差异。
- 未来应探索疾病部位选择驱动因素的研究。
研究设计与样本
- 通过2020年1月公开的学术放射肿瘤科科室网站收集教职人员的性别和诊治疾病部位。
- 共纳入1337名学术放射肿瘤科教职人员,其中408名(30.5%)被识别为女性。
- 使用卡方分析评估治疗各疾病部位的女性教职人员比例差异。
主要发现
- 乳腺、妇科和儿科中女性教职人员比例最大(均>40%;P<.001)。
- 53%的女性学术放射肿瘤学教职人员治疗乳腺(P<.001)。
- 泌尿生殖、胸部和头颈中女性教职人员比例最小(均<25%;P<.001)。
- 女性学术放射肿瘤学教职人员治疗乳腺和妇科恶性肿瘤的可能性是男性教职人员的两倍(风险比[RR] 2.01 [95%CI 1.75-2.50];P<.001 和 RR 2.06 [95%CI 1.72-2.79];P<.001)。
- 男性学术放射肿瘤学教职人员治疗泌尿生殖系统癌症的可能性是女性的三倍(RR 0.40 [95%CI 0.34-0.48];P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Because some stakeholders within medicine seek to diversify and attain greater workforce equity, it is critical to understand gender-based divisions within specialization. Radiation oncology (RO) has one of the smallest proportions of women representation of all specialties, and to our knowledge, no prior studies have investigated gender differences in all the disease site specializations within RO. Thus, we analyzed the relationship between gender and disease site(s) treated in academic RO (ARO). METHODS AND MATERIALS: Faculty gender and disease site(s) treated by faculty from ARO departments were collected via publicly available department websites in January 2020. X2 analyses were conducted to assess differences between the proportions of women faculty treating each disease site. RESULTS: Of 1337 ARO faculty, 408 (30.5%) were identified as women. Breast, gynecology, and pediatrics had the largest proportions of women faculty (all >40%; P < .001). A majority (53%; P < .001) of women ARO faculty treated breast. Genitourinary, thoracic, and head and neck had the smallest proportions of women faculty (all <25%; P < .001). Women ARO faculty were twice as likely to treat breast and gynecologic malignancies compared with men faculty (risk ratio [RR] with 95% CI, 2.01 [1.75-2.50]; P < .001 and RR [95% CI], 2.06 [1.72-2.79]; P <.001, respectively). Men ARO faculty were 3 times more likely to treat genitourinary cancer compared with women faculty (RR [95% CI], 0.40 [0.34-0.48]; P < .001). There was no difference in the mean number of disease sites treated between women and men ARO faculty (2.63 vs 2.53; P = .29). CONCLUSIONS: Gender differences in disease site specialization were observed in ARO. Future research into the drivers of disease site selection should be explored.
引用
- Corrigan KL, Bankston ME, Holliday EB, et al. Disease Site Specialization in the Academic Radiation Oncology Workforce: Evidence of Gender Differences. Int J Radiat Oncol Biol Phys. 2024. PMID: 38897359. doi:10.1016/j.ijrobp.2024.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。